Affymetrix, Inc.
New Cytogenetics Products Offer Best Overall Approach for Detection of Chromosome Aberrations
Published in Cancer Weekly, April 7th, 2009
“We worked closely with the cytogenetics community to develop these products,” said Jay Kaufman, vice president of product marketing at Affymetrix. “We identified critical and high-demand features specific to cytogenetics studies, and leveraged our proven microarray platform to develop products that delivered those features. Then, we streamlined and simplified workflows and protocols from sample preparation to data...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-04-07)
More Articles from Cancer Weekly
- Journal of the National Cancer Institute
Human papillomavirus genotype distribution in New Mexico cervical cancers - World Journal of Gastroenterology
Automatic slicing system: Ex-vivo culture normal and cancerous pancreatic tissue - Cancer
Ezetimibe and Ezetimibe/Simvastatin Combo Pose No Increased Cancer Risk, Study Shows - Cancer Gene Therapy
Studies from Polytechnic University have provided new information about cancer gene therapy - Cancer Vaccines
Confirmation of Bogoch Replikins Influenza Patents by Harvard-CDC and Scripps-Crucell Data - Cancer Vaccines
Data on cancer vaccines discussed by R. Fontana and colleagues - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
